Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.

Tigen, ELİF; Tandogdu, Zafer; Ergonul, Onder; Altinkanat, GÜLŞEN; Gunaydin, Bilal; Ozgen, Mahir; Sariguzel, Nevin; Sengel, BUKET; Odabasi, ZEKAVER; Cek, Mete; Tokuc, Resit; Turkeri, Levent; Mulazimoglu, LÜTFİYE; Korten, VOLKAN

doi:10.1016/j.urology.2014.04.060

Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.

Atıf İçin Kopyala

Tigen E., Tandogdu Z., Ergonul O., Altinkanat G., Gunaydin B., Ozgen M., ...Daha Fazla

Urology, cilt.84, sa.5, ss.1008-15, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 84 Sayı: 5
Basım Tarihi: 2014
Doi Numarası: 10.1016/j.urology.2014.04.060
Dergi Adı: Urology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1008-15
Marmara Üniversitesi Adresli: Evet

Özet

OBJECTIVE To determine the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (PE) fecal carriage in patients that undergo transrectal ultrasonography-guided biopsy (TRUSbx) and its relationship with post-biopsy infections.